By Industry News
Miami, FL – November 10, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company that specializes in the clinical application of human birth tissue-based products, announced today that it had joined forces with key stakeholder groups around the nation who are advocating for diabetes awareness and optimal patient care, especially in chronic, debilitating conditions like late stage (Wagner Grade 3 and 4) Complex Diabetic Foot Ulcers (DFUs). Amniox has rolled out a month-long virtual campaign, #DFUAvengers, targeting health care professionals who treat patients living with chronic wounds.